Hybrid Molecule SA-10 Delivered via PLGA Nanosuspension Shows Potential in Protecting Retinal Cells

A recent study has examined the potential of a hybrid molecule, SA-10, combined with a poly(lactic-co-glycolic acid) (PLGA) nanosuspension in protecting retinal cells. Researchers led by Pham et al. explored the neuroprotective properties of this innovative formulation, which may offer new avenues for addressing neurodegenerative diseases affecting retinal health. The study focused on evaluating the effectiveness of SA-10 and its delivery through PLGA nanosuspension in safeguarding retinal cells from damage.

The research highlights the significance of combining SA-10 with PLGA nanosuspension to enhance its protective capabilities. Poly(lactic-co-glycolic acid), commonly used in drug delivery systems, was utilized to create a stable nanosuspension that improves the bioavailability and targeted delivery of SA-10 to retinal cells. The findings suggest that this hybrid approach could play a role in mitigating cellular damage associated with neurodegenerative conditions impacting vision. Further studies are expected to explore its broader applications and long-term effects on retinal health.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 3, 2025

Related posts:

CDMO Pricing Guide Highlights Capacity Utilization as Key Cost Driver Sudeep Pharma Files DRHP with SEBI to Raise ₹95 Crore Through IPO RedHill Biopharma Signs $1.8 Million Licensing Deal to Introduce FDA-Approved H. pylori Therapy Talicia in Middle East Pfizer Reportedly Considering Sale of Stake in BioNTech Amid Continued Collaboration

Author

GOAI